Medtronic PLC operates within the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medtronic PLC with three other medical equipment manufacturers in North America: Steris PLC (2019 sales of $2.78 billion of which 48% was Healthcare Products), ResMed Inc. ($2.61 billion of which 100% was Medical Equipment), and Haemonetics Corporation ($967.58 million of which 41% was North America Plasma).

Sales Analysis. During the year ended April of 2019, sales at Medtronic PLC were $30.56 billion. This is an increase of 2.0% versus 2018, when the company's sales were $29.95 billion. This was the fifth consecutive year of sales increases at Medtronic PLC (and since 2014, sales have increased a total of 80%). Sales of Diabetes saw an increase that was more than double the company's growth rate: sales were up 11.7% in 2019, from $2.14 billion to $2.39 billion. Medtronic PLC also saw significant increases in sales in Restorative Therapies Group (up 5.7% to $8.18 billion) . Not all segments of Medtronic PLC experienced an increase in sales in 2019: sales of Minimially Invasive Therapies Group fell 2.7% to $8.48 billion.